Optical-resolution photoacoustic microscopy (OR-PAM) provides superb optical absorption contrast for red blood cells (RBCs), which makes it ideal for in vivo microvasculature imaging. In comparison, optical coherence tomography (OCT), widely used for tissue microstructure imaging, provides high optical scattering contrast. The two contrast mechanisms are highly complementary. In this work, we combined OR-PAM and OCT into a single, dual-modality imaging instrument for in vivo mouse eye imaging. We demonstrated in vivo dual-modality imaging of the anterior segment of mouse eyes with laser pulse energy within the ANSI laser safety standard.
INTRODUCTION
Optical coherence tomography (OCT) [1] has become the mainstream imaging technology in ophthalmology. OCT has high sensitivity in imaging depth-resolved subsurface tissue structures using coherence gating and coherence amplification. Contrast mechanisms such as Doppler contrast, polarization contrast, spectroscopic contrast, and speckle contrast are important in many OCT applications. The above contrast mechanisms are based on optical scattering properties. In ophthalmology, OCT technology does not satisfy all clinical needs. Only limited functional imaging information is provided by the Doppler OCT. Invasive fluorescein angiography (FA) and indocyanine green angiography (ICGA) are still widely used in eye clinics. In vivo, label-free imaging technologies with endogenous contrast are always desirable for replacing the invasive imaging technologies. The recent development of opticalresolution photoacoustic microscopy (OR-PAM) [2] , which is based on detecting the optical absorption contrast mechanism, introduces a novel member into the family of optical diagnosing tomography. OR-PAM, along with darkfield acoustic-resolution photoacoustic microscopy (AR-PAM), photoacoustic computed tomography and thermoacoustic tomography, promises to have a substantial impact on biomedical applications in the near future [3, 4] . In fact, PAM and OCT are complementary technologies since they provide different contrasts. In this work, we combined OR-PAM and OCT within a single, dual-modality imaging instrument for in vivo mouse eye imaging. We demonstrated in vivo dual-modality (OCT and OR-PAM) imaging of the anterior segment in mouse eyes with laser pulse energy within the ANSI laser safety standard.
MATERIALS AND METHODS
Schematic dual-modality OCT/PAM imaging system setup The dual-modality OCT/PAM imaging system setup is shown in Figure 1 . The dual-modality imaging probe, which is shown as a green dashed box in Figure 1 , will be discussed in next section. The whole system includes a traditional Fourier-domain OCT system [5] , a 532 nm pulsed laser, one AO card (NI-6713), one A/D card (NI-5124), and the dualmodality imaging probe. The AO card was used to generate trigger signals to fire laser pulses and move the 1D stage. The PAM signal detected by the ultrasonic transducer was detected by the NI-5124 card. The pulsed laser has a pulse duration of 2 ns. Its pulse repetition rate was set as 5000. The pulse energy was set as 60 nJ for in vivo imaging.
The Fourier-domain OCT system includes a broadband light source (Superlum D890, 150 nm 3dB bandwidth, center wavelength 890 nm), an optical isolator, a 20/80 split-ratio 2 by 2 fiber coupler, a reference arm, a sample arm, and a spectrometer in the detection arm. The customized spectrometer was used to detect low back-scattered light from the sample. The CCD line-scan camera has 2048 pixels. The pixel size is 14 µm × 14 µm. The maximum frame rate of CCD-line scan camera is 29,000. OCT system's signal-to-noise ratio (SNR) was measured as 100 dB with 750 µw sample arm power and 50 µs CCD A-line integration time. Comparing to the SNR measured at the imaging depth of 50 µm, a 9 dB of SNR roll-off was observed at the imaging depth of 2 mm. The dual-modality imaging system was operating at 5000 Alines per second, which was limited by the pulse repetition rate of the laser. Figure 2 shows the schematic setup of the dual-modality OCT/PAM imaging probe. The sample arm light from the OCT system was connected to the dual-modality probe through a HI-780 single mode fiber. The 532 nm pulsed laser was connected to the probe with a 460 HP single mode fiber. A diachronic mirror was used to combine the collimated OCT sample arm light and 532 nm PAM excitation laser. A Galvo mirror, which was located at the front focus of an objective (NA 0.1) was used to deflect the laser beams. A water cube comprising two isosceles right-angle water prisms and a glass plate between them was employed for light wave delivery and acoustic wave coupling. After passing through the water cube, the laser beam was focused at least 200 µm below the tissue surface. Upon the absorption of the laser pulse by the tissue, photoacoustic waves were generated. Thereafter, it was reflected by the glass plate and detected by the ultrasonic transducer. The ultrasonic transducer (GE, 25 MHz bandwidth), having a line focus along the optical scan axis, collected photoacoustic signals from the fast optical scan axis (X axis) without being moved mechanically. The whole probe was attached to a one-dimensional mechanical stage, which scanned perpendicularly to the fast optical scan axis. The OCT A-line image and PAM Aline image were acquired sequentially in time. Figure 3 shows the schematic OCT/PAM dual-modality imaging system software architecture. The software was written in Visual C ++. Multiple threads were used for real time data acquisition (DAQ), data processing (DAP) and image presentation tasks. The DAQ thread acquired data from both the frame grabber and the NI-5124 card. Raw data was sent to the streaming buffer for documentation. Data frames were sent to different DAP threads for real time data processing and data presentation. The number of DAP threads were scalable in software.
Imaging procedures
All experimental animal procedures were carried out in conformity with the laboratory animal protocol approved by the School of Medicine Animal Studies Committee of Washington University in St. Louis. Nude mice (Hsd, Athymic Nude-Foxn1 NU , Harlan Co.) were anesthetized by intraperitoneal (IP) injection of a cocktail containing Ketamine (100 mg/kg) and Xylazine (10mg/kg). A custom-made animal holder was used to restrain the animal. A breathing device (E-Z Anesthesia, Euthanex Corp.) was employed to maintain the anesthesia status after the IP injection. The mouse was placed under a water tank to maximize the coupled acoustic wave for best ultrasonic detection.
In order to acquire a 3D image, an imaging area of 4 mm × 4 mm was scanned. The step size in both lateral directions was 5 µm. The size of 3D PAM data set was 800 × 800 × 200 while the size of 3D OCT data set was 800 × 800 × 2048.
RESULTS

Fig 3.
In vivo, label-free mouse ocular anterior segment imaging in (A) OCT mode (B) PAM mode and (C) dual-modality mode Figure 3 shows the in vivo, label-free ocular anterior segment imaging results. Figure 3A showed only a 3D OCT image of the anterior segment of the mouse eye. Figure 3B showed only a 3D PAM image of the anterior segment of the mouse eye. Combing the contrast in Fig 3A and Fig 3B, Figure 3C showed a dual-modality 3D OCT/PAM image of the anterior segment of the mouse eye. As shown in Figure 3B , PAM has superb contrast to red blood cells in vasculature while OCT has good optical scattering contrast in documenting ocular anterior segment structure. The combination of contrast mechanisms of OCT and PAM may be helpful in diagnosing anterior segment eye diseases in the future.
LASER SAFETY CONSIDERATIONS
The major laser safety concern for the anterior segment of eye imaging is the safety of anterior segment tissue instead of retinal tissue [6] . We assume the laser focus is 200 μm below the surface tissue. The surface illumination area (NA = 0.1) is 30 μm. We scanned 4 mm using 800 points. The step size was 5 μm. Thus the repetitive pulse number on the illumination area was 6. The repetitive pulse limit can be calculated as the following:
MPE RP = n -0.25 × MPE SP = 6 -0.25 × 20 mJ/cm 2 = 12.78 mJ/cm 2 After multiplying the MPE RP with surface illumination area, the maximum permissible pulse energy is calculated as 90 nJ per pulse. Thus our pulse energy of 60 nJ per pulse is within safety limit.
CONCLUSIONS
In vivo, real time imaging and visualization of both microvasculature and microstructure simultaneously are desirable for many biomedical applications. We demonstrated in vivo dual-modality (OCT and OR-PAM) imaging of the anterior segment in a mouse eye with laser pulse energy within ANSI laser safety standard. The endogenous contrasts make this instrument safer than the conventional fluorescence dye based imaging devices in diagnosing anterior segment eye diseases.
